Abstract
摘要
相似文献
1
Placebos and suicide.安慰剂与自杀
Harv Ment Health Lett. 2000 Aug;17(2):6.
2
Are concerns about the ethics of placebos a stalking horse for other issues?对安慰剂伦理问题的担忧是否是其他问题的幌子？
Am J Bioeth. 2002 Spring;2(2):17-9. doi: 10.1162/152651602317533569.
3
The placebo problem remains.安慰剂问题依然存在。
Arch Gen Psychiatry. 2000 Apr;57(4):321-2. doi: 10.1001/archpsyc.57.4.321.
4
Statistical analysis to settle ethical issues?统计分析能解决伦理问题吗？
Arch Gen Psychiatry. 2000 Apr;57(4):327-8. doi: 10.1001/archpsyc.57.4.327.
5
What conditions are necessary to assess antidepressant efficacy?评估抗抑郁药疗效需要哪些必要条件？
Arch Gen Psychiatry. 2000 Apr;57(4):323-4. doi: 10.1001/archpsyc.57.4.323.
6
Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database.抗抑郁药物临床试验中接受安慰剂治疗患者的症状减轻与自杀风险：对美国食品药品监督管理局数据库的分析
Arch Gen Psychiatry. 2000 Apr;57(4):311-7. doi: 10.1001/archpsyc.57.4.311.
7
Placebo protects subjects from nonresponse: a paradox of power.安慰剂可保护受试者免于无反应：一种力量的悖论。
Arch Gen Psychiatry. 2000 Apr;57(4):329-30. doi: 10.1001/archpsyc.57.4.329.
8
Antidepressants and suicide prevention in Hungary.匈牙利的抗抑郁药与自杀预防
Acta Psychiatr Scand. 2001 Mar;103(3):238-9. doi: 10.1034/j.1600-0447.2001.103003238.x.
9
Prevention of suicide. The Swedish PTD Committee.自杀预防。瑞典药品不良反应委员会。
Lancet. 1992 Nov 14;340(8829):1233-4.
10
Suicidal risk in antidepressant drug trials.抗抑郁药物试验中的自杀风险。
Arch Gen Psychiatry. 2006 Mar;63(3):246-8. doi: 10.1001/archpsyc.63.3.246.
Zotero 插件